Global Thalassemia Market Size, Status and Forecast 2020-2026
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered: Ranking by Thalassemia Revenue
- 1.4 Market by Type
- 1.4.1 Global Thalassemia Market Size Growth Rate by Type: 2020 VS 2026
- 1.4.2 Iron Chelating Drugs
- 1.4.3 Others
- 1.5 Market by Application
- 1.5.1 Global Thalassemia Market Share by Application: 2020 VS 2026
- 1.5.2 Hospital
- 1.5.3 Clinic
- 1.5.4 Research Institute
- 1.5.5 Laboratories
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Global Thalassemia Market Perspective (2015-2026)
- 2.2 Global Thalassemia Growth Trends by Regions
- 2.2.1 Thalassemia Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 Thalassemia Historic Market Share by Regions (2015-2020)
- 2.2.3 Thalassemia Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
- 2.3.5 Thalassemia Market Growth Strategy
- 2.3.6 Primary Interviews with Key Thalassemia Players (Opinion Leaders)
3 Competition Landscape by Key Players
- 3.1 Global Top Thalassemia Players by Market Size
- 3.1.1 Global Top Thalassemia Players by Revenue (2015-2020)
- 3.1.2 Global Thalassemia Revenue Market Share by Players (2015-2020)
- 3.1.3 Global Thalassemia Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.2 Global Thalassemia Market Concentration Ratio
- 3.2.1 Global Thalassemia Market Concentration Ratio (CR5 and HHI)
- 3.2.2 Global Top 10 and Top 5 Companies by Thalassemia Revenue in 2019
- 3.3 Thalassemia Key Players Head office and Area Served
- 3.4 Key Players Thalassemia Product Solution and Service
- 3.5 Date of Enter into Thalassemia Market
- 3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Thalassemia Historic Market Size by Type (2015-2020)
- 4.2 Global Thalassemia Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
- 5.1 Global Thalassemia Market Size by Application (2015-2020)
- 5.2 Global Thalassemia Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America Thalassemia Market Size (2015-2020)
- 6.2 Thalassemia Key Players in North America (2019-2020)
- 6.3 North America Thalassemia Market Size by Type (2015-2020)
- 6.4 North America Thalassemia Market Size by Application (2015-2020)
7 Europe
- 7.1 Europe Thalassemia Market Size (2015-2020)
- 7.2 Thalassemia Key Players in Europe (2019-2020)
- 7.3 Europe Thalassemia Market Size by Type (2015-2020)
- 7.4 Europe Thalassemia Market Size by Application (2015-2020)
8 China
- 8.1 China Thalassemia Market Size (2015-2020)
- 8.2 Thalassemia Key Players in China (2019-2020)
- 8.3 China Thalassemia Market Size by Type (2015-2020)
- 8.4 China Thalassemia Market Size by Application (2015-2020)
9 Japan
- 9.1 Japan Thalassemia Market Size (2015-2020)
- 9.2 Thalassemia Key Players in Japan (2019-2020)
- 9.3 Japan Thalassemia Market Size by Type (2015-2020)
- 9.4 Japan Thalassemia Market Size by Application (2015-2020)
10 Southeast Asia
- 10.1 Southeast Asia Thalassemia Market Size (2015-2020)
- 10.2 Thalassemia Key Players in Southeast Asia (2019-2020)
- 10.3 Southeast Asia Thalassemia Market Size by Type (2015-2020)
- 10.4 Southeast Asia Thalassemia Market Size by Application (2015-2020)
11 India
- 11.1 India Thalassemia Market Size (2015-2020)
- 11.2 Thalassemia Key Players in India (2019-2020)
- 11.3 India Thalassemia Market Size by Type (2015-2020)
- 11.4 India Thalassemia Market Size by Application (2015-2020)
12 Central & South America
- 12.1 Central & South America Thalassemia Market Size (2015-2020)
- 12.2 Thalassemia Key Players in Central & South America (2019-2020)
- 12.3 Central & South America Thalassemia Market Size by Type (2015-2020)
- 12.4 Central & South America Thalassemia Market Size by Application (2015-2020)
13 Key Players Profiles
- 13.1 Bluebird bio, Inc.
- 13.1.1 Bluebird bio, Inc. Company Details
- 13.1.2 Bluebird bio, Inc. Business Overview
- 13.1.3 Bluebird bio, Inc. Thalassemia Introduction
- 13.1.4 Bluebird bio, Inc. Revenue in Thalassemia Business (2015-2020))
- 13.1.5 Bluebird bio, Inc. Recent Development
- 13.2 Acceleron Pharma, Inc.
- 13.2.1 Acceleron Pharma, Inc. Company Details
- 13.2.2 Acceleron Pharma, Inc. Business Overview
- 13.2.3 Acceleron Pharma, Inc. Thalassemia Introduction
- 13.2.4 Acceleron Pharma, Inc. Revenue in Thalassemia Business (2015-2020)
- 13.2.5 Acceleron Pharma, Inc. Recent Development
- 13.3 Celgene Corporation
- 13.3.1 Celgene Corporation Company Details
- 13.3.2 Celgene Corporation Business Overview
- 13.3.3 Celgene Corporation Thalassemia Introduction
- 13.3.4 Celgene Corporation Revenue in Thalassemia Business (2015-2020)
- 13.3.5 Celgene Corporation Recent Development
- 13.4 GlaxoSmithKline plc
- 13.4.1 GlaxoSmithKline plc Company Details
- 13.4.2 GlaxoSmithKline plc Business Overview
- 13.4.3 GlaxoSmithKline plc Thalassemia Introduction
- 13.4.4 GlaxoSmithKline plc Revenue in Thalassemia Business (2015-2020)
- 13.4.5 GlaxoSmithKline plc Recent Development
- 13.5 Incyte Corporation
- 13.5.1 Incyte Corporation Company Details
- 13.5.2 Incyte Corporation Business Overview
- 13.5.3 Incyte Corporation Thalassemia Introduction
- 13.5.4 Incyte Corporation Revenue in Thalassemia Business (2015-2020)
- 13.5.5 Incyte Corporation Recent Development
- 13.6 Gamida Cell
- 13.6.1 Gamida Cell Company Details
- 13.6.2 Gamida Cell Business Overview
- 13.6.3 Gamida Cell Thalassemia Introduction
- 13.6.4 Gamida Cell Revenue in Thalassemia Business (2015-2020)
- 13.6.5 Gamida Cell Recent Development
- 13.7 Kiadis Pharma
- 13.7.1 Kiadis Pharma Company Details
- 13.7.2 Kiadis Pharma Business Overview
- 13.7.3 Kiadis Pharma Thalassemia Introduction
- 13.7.4 Kiadis Pharma Revenue in Thalassemia Business (2015-2020)
- 13.7.5 Kiadis Pharma Recent Development
- 13.8 La Jolla Pharmaceutical Company
- 13.8.1 La Jolla Pharmaceutical Company Company Details
- 13.8.2 La Jolla Pharmaceutical Company Business Overview
- 13.8.3 La Jolla Pharmaceutical Company Thalassemia Introduction
- 13.8.4 La Jolla Pharmaceutical Company Revenue in Thalassemia Business (2015-2020)
- 13.8.5 La Jolla Pharmaceutical Company Recent Development
- 13.9 IONIS Pharmaceuticals
- 13.9.1 IONIS Pharmaceuticals Company Details
- 13.9.2 IONIS Pharmaceuticals Business Overview
- 13.9.3 IONIS Pharmaceuticals Thalassemia Introduction
- 13.9.4 IONIS Pharmaceuticals Revenue in Thalassemia Business (2015-2020)
- 13.9.5 IONIS Pharmaceuticals Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
- 15.2 Disclaimer
Thalassemia market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Thalassemia market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Bluebird bio, Inc.
Acceleron Pharma, Inc.
Celgene Corporation
GlaxoSmithKline plc
Incyte Corporation
Gamida Cell
Kiadis Pharma
La Jolla Pharmaceutical Company
IONIS Pharmaceuticals
Market segment by Type, the product can be split into
Iron Chelating Drugs
Others
Market segment by Application, split into
Hospital
Clinic
Research Institute
Laboratories
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America